课题基金 / 基金详情

DOUBLE BLIND, PLACEBO CONTROLLED, RANDOMIZED STUDY ON EFFICACY OF IBANDRONATE

DOUBLE BLIND, PLACEBO CONTROLLED, RANDOMIZED STUDY ON EFFICACY OF IBANDRONATE
关于伊班膦酸钠疗效的双盲、安慰剂对照、随机研究
批准号：
6290933
负责人：
C. CONRAD JOHNSTON
金额：
$1.7万
依托单位：
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
依托单位国家：
美国
项目类别：
财政年份：
1998
资助国家：
美国
项目状态：
已结题
起止时间：
1998-12-01 至 1999-11-30
来源：
https://reporter.nih.gov/project-details/6290933
关键词：
bone fracture breast neoplasm /cancer diagnosis clinical research diphosphonate drug screening /evaluation female human subject human therapy evaluation oral administration osteoporosis postmenopause skeletal disorder chemotherapy

项目摘要

项目成果

C. CONRAD JOHNSTON的其他基金

相关文献

中文摘要
翻译
这项为期三年的第三阶段研究的目的是调查 伊班磷酸钠长期治疗慢性粒细胞白血病的疗效观察 绝经后骨质疏松症远期疗效评价 间歇性和长期连续口服治疗的发病率 以新的椎体骨折为主要终点。具体目标 确定伊班磷酸钠是否能预防女性骨折和骨丢失 确诊为绝经后骨质疏松症的患者， 与口服伊班磷酸钠相关的副作用。
英文摘要
The purpose of this three year phase III study is to investigate the therapeutic effect Ibandronate in the long term treatment of postmenopausal osteoporosis by evaluating the efficacy of long term intermittent and long termcontinuous oral treatment using the incidence of new vertebral fractures as the primary endpoint. The specific objectives to determine whether Ibandronate prevents fractures and bone loss in women with established postmenopausal osteoporosis, to determine the type of side effects associated with the oral administration of Ibandronate.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ROLE OF SEX STEROIDS IN AGE-RELATED BONE LOSS
RALOXIFENE HCL AND PLACEBO IN PREVENTION OF OSTEOPOROSIS IN POSTMENOPAUSALS
RALOXIFENE HCL AND PLACEBO IN PREVENTION OF OSTEOPOROSIS IN POSTMENOPAUSALS
DOUBLE BLIND RANDOMIZED PLACEBO CONTROLLED PARALLEL GROUP MULTICENTER STUDY